نتایج جستجو برای: essential medicines list

تعداد نتایج: 487564  

Journal: :Clinical Pharmacology & Therapeutics 2009

2015
Nicola Magrini Jane Robertson Gilles Forte Bernadette Cappello Lorenzo P Moja Kees de Joncheere Marie-Paule Kieny

Perspectives In 1977, the World Health Organization (WHO) published its first Model List of Essential Medicines. 1 This year, the Expert Committee for the Selection and Use of Medicines will consider requests to include high-cost medicines for cancer , hepatitis C, multidrug-resistant tuberculosis and new oral anticoagulants on the model list. These applications challenge perceptions of essenti...

Journal: :Indian journal of physiology and pharmacology 2012
Seetharama G Rao Dixon Thomas Seeba Zachariah M S Kannan Gerardo Alvarez-Uria

OBJECTIVE Fixed drug combinations are a major marketing strategy in India but it can compromise the rational use of medicines. In this study we compared the fixed drug combinations and dosage forms in the hospital pharmacy before and after introducing the essential drug list. We also compared the Hospital Essential Drug List (HEDL) 2011 with the World Health Organization (WHO) Essential Drug Li...

2017
Nav Persaud Taehoon Lee Haroon Ahmad Winny Li Michael Sergio Taglione Yathavan Rajakulasingam Norman Umali Andrew Boozary Richard H Glazier Tara Gomes Stephen W Hwang Peter Jüni Michael Law Muhammad M Mamdani Braden Manns Danielle Martin Steve Morgan Paul Oh Andrew David Pinto Baiju R Shah Frank M Sullivan Kevin E Thorpe Karen Tu Andreas Laupacis

INTRODUCTION Cost-related non-adherence to medicines is common in low-income, middle-income and high-income countries such as Canada. Medicine non-adherence is associated with poor health outcomes and increased mortality. This randomised trial will test the impact of a carefully selected list of essential medicines at no charge (compared with usual medicine access) in primary care patients repo...

Journal: :Bulletin of the World Health Organization 2012
Octavio Gómez-Dantés Veronika J Wirtz Michael R Reich Paulina Terrazas Maki Ortiz

PROBLEM As countries expand health insurance coverage, their expenditures on medicines increase. To address this problem, WHO has recommended that every country draw up a list of essential medicines. Although most medicines on the list are generics, in many countries patented medicines represent a substantial portion of pharmaceutical expenditure. APPROACH To help control expenditure on paten...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016
Lawrence N Shulman Claire M Wagner Ronald Barr Gilberto Lopes Giuseppe Longo Jane Robertson Gilles Forte Julie Torode Nicola Magrini

PURPOSE A great proportion of the world's cancer burden resides in low- and middle-income countries where cancer care infrastructure is often weak or absent. Although treatment of cancer is multidisciplinary, involving surgery, radiation, systemic therapies, pathology, radiology, and other specialties, selection of medicines that have impact and are affordable has been particularly challenging ...

2016
Jane Robertson Ronald Barr Lawrence N Shulman Gilles B Forte Nicola Magrini

OBJECTIVE To examine, for essential anti-cancer medicines, the alignment of national lists of essential medicines and national reimbursable medicines lists with the World Health Organization's (WHO's) Model Lists. METHODS National medicine lists for 135 countries with per-capita gross national incomes below 25 000 United States dollars in 2015 were compared with WHO's 2013 and 2015 Model List...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید